The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.3. rezultāts no 83.
26. lappuse
... Industry : A Special Target The pharmaceutical industry has been made the special tar- get of government patent policy involving discoveries through research supported by federal grants . This is something of a para- dox when we ...
... Industry : A Special Target The pharmaceutical industry has been made the special tar- get of government patent policy involving discoveries through research supported by federal grants . This is something of a para- dox when we ...
27. lappuse
... industry . These factors permeate our industry's re- search policies . The necessarily greater risks in a research - oriented industry , the difficulty of making and evaluating discoveries in this field and apply- ing them to therapy ...
... industry . These factors permeate our industry's re- search policies . The necessarily greater risks in a research - oriented industry , the difficulty of making and evaluating discoveries in this field and apply- ing them to therapy ...
680. lappuse
... INDUSTRY Research is the life blood of the pharmaceutical industry . It pours hundreds of millions of dollars into research , somewhere in the neighborhood of 9-10 per cent of its net sales compared to 5-6 % in industry as a whole . In ...
... INDUSTRY Research is the life blood of the pharmaceutical industry . It pours hundreds of millions of dollars into research , somewhere in the neighborhood of 9-10 per cent of its net sales compared to 5-6 % in industry as a whole . In ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention